crisnatol has been researched along with phenanthrenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, DJ | 1 |
| Craig, JB; Harman, GS; Koeller, J; Kuhn, JG; Lucas, VS; Luther, JS; Turner, JN; Tuttle, RL; Tweedy, DA; Weiss, GR | 1 |
2 other study(ies) available for crisnatol and phenanthrenes
| Article | Year |
|---|---|
In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator.
Topics: Antineoplastic Agents; Cell Survival; Chrysenes; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Intercalating Agents; Phenanthrenes; Propylene Glycols; Time Factors; Tumor Cells, Cultured | 1989 |
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule.
Topics: Adult; Aged; Antineoplastic Agents; Arrhythmias, Cardiac; Blood Pressure; Chrysenes; Digestive System; Drug Administration Schedule; Drug Evaluation; Electroencephalography; Female; Humans; Male; Middle Aged; Neoplasms; Nervous System; Phenanthrenes; Propylene Glycols | 1988 |